Unexpected high mortality associated with very low lipoprotein(a) after acute myocardial infarction: Identifying the unknown

Felicita Andreotti; Massimo Massetti; Aldo Maggioni

doi:10.1016/j.ejim.2021.07.006

Back

Unexpected high mortality associated with very low lipoprotein(a) after acute myocardial infarction: Identifying the unknown

Letter 2021 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2010

Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

Kent R. Nilsson, Sana M. Al‐Khatib, Yi Zhou, Karen S. Pieper, H. D. White, Aldo Maggioni, Lars Køber, Christopher B Granger, E. F. Lewis, John J.V. McMurray, Robert M. Califf, E. J. Velazquez

Article2012

Mortality Risk Associated with AF in Myocardial Infarction Patients.

Rajiv Sankaranarayanan

Article1998

Very early administration of ACE-inhibitors in acute myocardial infarction

Aldo Maggioni, Enrico Geraci

Article2004

The risk of acute myocardial infarction after stopping drinking

Eva Negri, Carlo La Vecchia, Claudio Pelucchi, Alessandra Tavani

Article2008

High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

Rachel Anderson, Marc A. Pfeffer, Jens Jakob Thune, John J.V. McMurray, Robert M. Califf, Eric J. Velazquez, Harvey D. White, Jean L. Rouleau, Hicham Skali, Aldo Maggioni, Scott D. Solomon